Liquidia falls after Q2 profit miss

Liquidia

12/08/2026 14:58

** Shares of drugmaker Liquidia Corp's shares LQDA.O fall 2.8% to $85.6 
** LQDA posts Q2 profit of $74.72 mln, below analysts' estimates of $77.22 mln, data compiled by LSEG
** Net product sales up by $170.4 mln, compared to $6 mln last year and above estimates of $168.54 mln, boosted by Yutrepia sales
** Reports its hypertension drug Yutrepia received about 5,900 unique patient prescriptions since its launch in June 2025
** As of last close, stock more than doubled in value YTD

(Reporting by Anand Gopal in Bengaluru)
((anandgopal.r@thomsonreuters.com))